Found 6 articles for: "Tazarotene Lotion"

Halobetasol Propionate/Tazarotene Lotion for Scalp Psoriasis: Efficacy in Itch Reduction, Disease Clearance, and Hair Appearance

August 2025 | Volume 24 | Issue 8 | Original Article | 752 | Copyright © August 2025

Clinical Profile of Halobetasol Propionate 0.01%/ Tazarotene 0.045% Lotion in Patients With Hyperkeratotic Plaque Psoriasis

June 2025 | Volume 24 | Issue 6 | Original Article | 590 | Copyright © June 2025

Meeting Patient Expectations of Topical Psoriasis Treatment: Evidence Supporting the Use of Fixed-Combination Halobetasol/Tazarotene Lotion

February 2023 | Volume 22 | Issue 2 | Original Article | 132 | Copyright © February 2023

Discordance between patient and clinician treatment goals and expectations can present a challenge to implementation of effective therapeutic plans. Because topical treatments are commonly used for pl...
Read More

Efficacy and Safety of Tazarotene Lotion, 0.045% in the Treatment of Truncal Acne Vulgaris

July 2022 | Volume 21 | Issue 7 | Original Article | 713 | Copyright © July 2022

Background: Although truncal acne is thought to have the same pathophysiology as facial acne, treatment response may differ based on body area involvement. Traditionally, prescribers ...
Read More

Fixed-Combination Halobetasol Propionate/Tazarotene Lotion for Psoriasis in Patients With 3%–5% Affected Body Surface Area

August 2021 | Volume 20 | Issue 8 | Original Article | 829 | Copyright © August 2021

Introduction: Patients with psoriasis and low body surface area (BSA) involvement often experience substantially reduced quality of life and may be candidates for topical therapies. F...
Read More

Successful Treatment of Lichen Amyloidosis Using a Fixed Combination of Halobetasol-Propionate and Tazarotene Lotion

March 2021 | Volume 20 | Issue 3 | Case Reports | 336 | Copyright © March 2021

Read More